Page last updated: 2024-11-03

propranolol and Adrenal Hyperplasia, Congenital

propranolol has been researched along with Adrenal Hyperplasia, Congenital in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Adrenal Hyperplasia, Congenital: A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourdeau, I1
Oble, S1
Magne, F1
Lévesque, I1
Cáceres-Gorriti, KY1
Nolet, S1
Awadalla, P1
Tremblay, J1
Hamet, P1
Fragoso, MC1
Lacroix, A1
Kim, JH1
Park, G1
Kim, SY1
Bae, HY1

Other Studies

2 other studies available for propranolol and Adrenal Hyperplasia, Congenital

ArticleYear
ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.
    European journal of endocrinology, 2016, Volume: 174, Issue:1

    Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenergic beta-Agonists; Adrenergic

2016
Thyrotoxic periodic paralysis with Graves' disease leading to the discovery of a hidden nonclassic 11β hydroxylase deficiency.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

    Topics: Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Drug Therapy, Combination; Graves Disease;

2013